JP2023516753A5 - - Google Patents

Info

Publication number
JP2023516753A5
JP2023516753A5 JP2022553583A JP2022553583A JP2023516753A5 JP 2023516753 A5 JP2023516753 A5 JP 2023516753A5 JP 2022553583 A JP2022553583 A JP 2022553583A JP 2022553583 A JP2022553583 A JP 2022553583A JP 2023516753 A5 JP2023516753 A5 JP 2023516753A5
Authority
JP
Japan
Prior art keywords
pharmaceutical product
patient
product according
salt
day
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022553583A
Other languages
English (en)
Japanese (ja)
Other versions
JP7749572B2 (ja
JP2023516753A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/020984 external-priority patent/WO2021178737A1/en
Publication of JP2023516753A publication Critical patent/JP2023516753A/ja
Publication of JP2023516753A5 publication Critical patent/JP2023516753A5/ja
Priority to JP2025157586A priority Critical patent/JP2026016375A/ja
Application granted granted Critical
Publication of JP7749572B2 publication Critical patent/JP7749572B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022553583A 2020-03-06 2021-03-05 Gla遺伝子の突然変異を有する患者におけるファブリー病を治療する方法 Active JP7749572B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025157586A JP2026016375A (ja) 2020-03-06 2025-09-24 Gla遺伝子の突然変異を有する患者におけるファブリー病を治療する方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062986297P 2020-03-06 2020-03-06
US62/986,297 2020-03-06
PCT/US2021/020984 WO2021178737A1 (en) 2020-03-06 2021-03-05 Methods of treating fabry disease in patients having a mutation in the gla gene

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025157586A Division JP2026016375A (ja) 2020-03-06 2025-09-24 Gla遺伝子の突然変異を有する患者におけるファブリー病を治療する方法

Publications (3)

Publication Number Publication Date
JP2023516753A JP2023516753A (ja) 2023-04-20
JP2023516753A5 true JP2023516753A5 (cg-RX-API-DMAC7.html) 2024-03-14
JP7749572B2 JP7749572B2 (ja) 2025-10-06

Family

ID=75267607

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022553583A Active JP7749572B2 (ja) 2020-03-06 2021-03-05 Gla遺伝子の突然変異を有する患者におけるファブリー病を治療する方法
JP2025157586A Pending JP2026016375A (ja) 2020-03-06 2025-09-24 Gla遺伝子の突然変異を有する患者におけるファブリー病を治療する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025157586A Pending JP2026016375A (ja) 2020-03-06 2025-09-24 Gla遺伝子の突然変異を有する患者におけるファブリー病を治療する方法

Country Status (25)

Country Link
US (1) US20230136297A1 (cg-RX-API-DMAC7.html)
EP (2) EP4527454A3 (cg-RX-API-DMAC7.html)
JP (2) JP7749572B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220152547A (cg-RX-API-DMAC7.html)
CN (1) CN115427040A (cg-RX-API-DMAC7.html)
AR (1) AR122390A1 (cg-RX-API-DMAC7.html)
AU (1) AU2021230371A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022017881A2 (cg-RX-API-DMAC7.html)
CA (1) CA3170718A1 (cg-RX-API-DMAC7.html)
CL (1) CL2022002423A1 (cg-RX-API-DMAC7.html)
DK (1) DK4114390T3 (cg-RX-API-DMAC7.html)
ES (1) ES3013813T3 (cg-RX-API-DMAC7.html)
FI (1) FI4114390T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20250179T1 (cg-RX-API-DMAC7.html)
HU (1) HUE070116T2 (cg-RX-API-DMAC7.html)
IL (1) IL296221A (cg-RX-API-DMAC7.html)
LT (1) LT4114390T (cg-RX-API-DMAC7.html)
MX (1) MX2022011030A (cg-RX-API-DMAC7.html)
PL (1) PL4114390T3 (cg-RX-API-DMAC7.html)
PT (1) PT4114390T (cg-RX-API-DMAC7.html)
RS (1) RS66530B1 (cg-RX-API-DMAC7.html)
SI (1) SI4114390T1 (cg-RX-API-DMAC7.html)
SM (1) SMT202500072T1 (cg-RX-API-DMAC7.html)
TW (1) TW202146020A (cg-RX-API-DMAC7.html)
WO (1) WO2021178737A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3840753T (lt) * 2018-08-20 2024-11-11 Amicus Therapeutics, Inc. Migalastatas skirtas naudoti fabry ligos gydymo būdui, pacientams turintiems gla geno mutaciją
KR20220044560A (ko) 2019-08-07 2022-04-08 아미쿠스 세라퓨틱스, 인코포레이티드 Gla 유전자에 돌연변이를 갖는 환자에서 파브리 질병을 치료하는 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274597B1 (en) 1998-06-01 2001-08-14 Mount Sinai School Of Medicine Of New York University Method of enhancing lysosomal α-Galactosidase A
EP2142197A4 (en) 2007-03-30 2010-11-10 Amicus Therapeutics Inc METHOD FOR THE TREATMENT OF MORBUS FABRY WITH PHARMACOLOGICAL CHAPTERONES
WO2009102895A2 (en) * 2008-02-12 2009-08-20 Amicus Therapeutics, Inc. Method to predict response to pharmacological chaperone treatment of diseases
WO2012125402A2 (en) * 2011-03-11 2012-09-20 Amicus Therapeutics, Inc. Dosing regimens for the treatment of fabry disease
US11034946B2 (en) * 2017-10-05 2021-06-15 Research Foundation Of The City University Of New York Glycosylation independent proteins

Similar Documents

Publication Publication Date Title
JP2021535107A5 (cg-RX-API-DMAC7.html)
JP2023519965A5 (cg-RX-API-DMAC7.html)
JP2023541430A5 (cg-RX-API-DMAC7.html)
HUE029677T2 (hu) Készítmények centrálisan mediált émelygés és hányás kezelésére
JP2006506378A5 (cg-RX-API-DMAC7.html)
JP2022536287A5 (cg-RX-API-DMAC7.html)
ES3060114T3 (cg-RX-API-DMAC7.html)
Gupta et al. Intermittent short duration therapy with fluconazole is effective for tinea capitis
RU2007119067A (ru) Средство для лечения синдрома раздраженного кишечника с преобладанием диареи
JP2022553888A5 (cg-RX-API-DMAC7.html)
JP2004525940A5 (cg-RX-API-DMAC7.html)
US20050038018A1 (en) Meloxicam compositions
US20050256131A1 (en) Pharmaceutical active substance combination and the use thereof
JP2025517509A5 (cg-RX-API-DMAC7.html)
JP2024531799A5 (cg-RX-API-DMAC7.html)
EP2830605B1 (en) A combination medicament comprising phenylephrine and paracetamol
FI4114390T3 (fi) Menetelmiä fabryn taudin hoitamiseksi potilaissa, joilla on mutaatio gla-geenissä
PT891186E (pt) Administração nasal de agentes para o tratamento de emese tardia
IE851848L (en) Propiophenone compound against sexual dysfunction
JP2024525760A5 (cg-RX-API-DMAC7.html)
CN1204881C (zh) 烯丙胺衍生物在制备治疗幽门螺杆菌感染和相关疾病的药物方面的用途
US20170087104A1 (en) Medicament
US20190224208A1 (en) Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation
JP2025521501A5 (cg-RX-API-DMAC7.html)
CA2612179A1 (en) A pharmaceutical composition comprising loratadine and its use to treat patients with upper respiratory mucosal congestion